Levobupivacaine on Heart Rate Variability (HRV) in Spinal Anesthesia

NCT ID: NCT00974961

Last Updated: 2010-03-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE4

Total Enrollment

70 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-09-30

Study Completion Date

2010-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to compare if the effect of levobupivacaine on autonomic nervous system smaller than that of bupivacaine.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Obtain the heart rate variability (in means and standard deviation, including the high frequency, low frequency and its ratio) data of before and after spinal anesthesia with ECG (and Heart Rate Variability Analyzer) in 2 groups. Meanwhile, record the blood pressure on each subject.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Spinal Anesthesia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Levobupivacaine

Lumbar puncture with Levobupivacaine for spinal anesthesia

Group Type ACTIVE_COMPARATOR

bupivacaine, levobupivacaine

Intervention Type DRUG

intrathecal injection 15\~20mg(for Levobupivacaine) or 10\~15mg(for Bupivacaine) once

Bupivacaine

Lumbar puncture with Bupivacaine for spinal anesthesia

Group Type ACTIVE_COMPARATOR

bupivacaine, levobupivacaine

Intervention Type DRUG

intrathecal injection 15\~20mg(for Levobupivacaine) or 10\~15mg(for Bupivacaine) once

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

bupivacaine, levobupivacaine

intrathecal injection 15\~20mg(for Levobupivacaine) or 10\~15mg(for Bupivacaine) once

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Indicated for spinal anesthesia

Exclusion Criteria

* Allergic reaction to local anesthetics
* Coagulopathy
* Severe spinal deformity
* Cardiac diseases
* Metabolic diseases (such as DM, thyroid or adrenal diseases)
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Taiwan University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Attending Stuff of Department of Anesthesiology

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Shih-Yu Chen

Role: STUDY_CHAIR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of Anesthesiology, National Taiwan University Hospital, Yun-Lin Branch

Yun-Lin County, , Taiwan

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Taiwan

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Shih-Yu Chen, M.D.

Role: CONTACT

886-5-5323911 ext. 5202

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Shih-Yu Chen

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

200903050M

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.